XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' Equity (Deficit): Stock Options Activity (Details) - Stock options - USD ($)
3 Months Ended 12 Months Ended
Mar. 26, 2022
Mar. 27, 2021
Dec. 25, 2021
Number of Shares      
Outstanding at the beginning of the period (in shares) 355,621    
Granted (in shares) 1,500    
Exercised (in shares) (9,156)    
Outstanding at the end of the period (in shares) 347,965   355,621
Exercisable at the end of the period (in shares) 212,610    
Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 146.03    
Granted (in dollars per share) 212.18    
Exercised (in dollars per share) 137.43    
Outstanding at the end of the period (in dollars per share) 146.54   $ 146.03
Exercisable at the end of the period (in dollars per share) $ 113.96    
Weighted Average Remaining Contractual Life (years)      
Outstanding 6 years 1 month 2 days   6 years 3 months 25 days
Exercisable at the end of the period 4 years 5 months 23 days    
Intrinsic Value      
Outstanding at the beginning of the period $ 39,320,600    
Outstanding at the end of the period 28,959,900   $ 39,320,600
Exercisable at the end of the period $ 23,874,000    
Weighted average assumptions and results used in estimation of fair value of options granted      
Risk free interest rate (as a percent) 1.88% 0.64%  
Expected life (years) 6 years 6 years  
Expected volatility (as a percent) 26.64% 25.05%  
Dividend yield (as a percent) 4.21% 2.77%  
Option fair value (in dollars per share) $ 33.92 $ 30.02